doi: 10.1159/000375530 142 NazMSGTehraniFRMajdHAAhmadiFOzgoliGFakariFRet al
In a combined analysis of three trials with 1,119 participants, individuals with PAM variants responded less effectively to GLP-1 drugs and were less likely to reach target HbA1c levels, a measure of long-term blood sugar control
VerretLMannEOHangGBBarthAMCobosIHoKet al
Both can hit the same protein target
In this exclusive report, Cure, a healthcare innovation ecosystem in New York City, and the Deerfield Institute unveil the results of a specialty physician survey, shedding light on their current prescribing of GLP-1RA medications, the challenges they face, and their expectations for future clinical applications of these drugs
1169/2011 **noch keine Referenzmenge vorhanden Verzehrsempfehlung: Tglich 1 Flschchen (entspr